Stories about Influenza

Subscribe to Influenza

07.12.2021 – 11:41

R-Biopharm AG

2
R-Biopharm receives approval of COVID-19 test in the UK under CTDA legislation

more
02.08.2021 – 16:35

ARTTIC Innovation GmbH

2
Press Release: Milestone reached in new antiviral treatment approach

More about the project via the VIROFIGHT website

more
10.06.2021 – 12:16

Shycocan
TNO research shows effectiveness of corona cannon

Rijswijk, Netherlands (ots/PRNewswire) - Addition due to incomplete information in the press release as sent on 4 June 2021 Analyses carried out by TNO in a BSL-3 laboratory cabinet showed that the corona gun had achieved a 94.9% reduction in the Covid -19 virus after 15 minutes. In the laboratory set-up, the (live) virus was located on stainless steel plates at 85 cm from the device. Earlier, the Dutch scientific ...

more
07.04.2021 – 09:53

Intravacc
Intravacc announces positive preclinical data for its SARS-CoV-2 nose spray vaccine

Bilthoven, Netherlands (ots/PRNewswire) - - Intranasal administration of OMV-Spike protected against challenge with SARS-CoV-2 - Intranasal vaccine administration has significant advantages over injectables - OMV technology is a powerful vaccine platform for future pandemics Intravacc, a global leader in translational research and development of viral and bacterial ...

more
02.03.2021 – 22:00

Studio Roosegaarde
World's First Urban Sun Cleans Public Space Of Coronavirus For Better Human Gatherings

Rotterdam, Netherlands (ots/PRNewswire) - Inspired by the light of the sun, and scientific research which proves that a new specific light can safely clean up to 99.9% of the coronavirus, Studio Roosegaarde launches the world's first Urban Sun. Daan Roosegaarde and his team of designers, external experts, and scientists challenged themselves to discover how the power ...

more
25.02.2021 – 14:01

Merck Serono GmbH
New Data Presented at ACTRIMS Forum 2021 Indicate MAVENCLAD®-treated RMS Patients Mount Protective Antibody Response to Common Vaccines

Darmstadt, Germany (ots/PRNewswire) - MAGNIFY-MS retrospective analysis demonstrates patients develop protective antibody levels for at least six months following seasonal influenza and varicella zoster vaccines, irrespective of vaccine timing relative to MAVENCLAD dosing Initial findings from the CLOCK-MS vaccine ...

more
02.11.2020 – 09:00

nal von minden GmbH

New: Combined rapid test for Covid-19 and influenza

more
23.09.2020 – 09:38

World Health Summit

COVID-19 and Global Health: Interview with Virologist Christian Drosten and World Health Summit President Detlev Ganten

more
11.09.2020 – 14:00

Merck Serono GmbH
New MAVENCLAD® Data at ACTRIMS-ECTRIMS MSVirtual2020 Meeting Highlight Rapid Onset of Action and Compelling Post-Approval Safety

Darmstadt, Germany (ots/PRNewswire) - In MAGNIFY-MS, patients experienced a rapid onset of action from end of Month 1 that was significant in all study periods versus baseline Post-approval safety analysis showed no increased risk of viral respiratory infections and lower rates of malignancy than in the clinical ...

more
20.07.2020 – 17:12

Viroclinics Biosciences
Davide Molho, DVM Joins Viroclinics Biosciences as Chief Executive Officer

Rotterdam, Netherlands (ots/PRNewswire) - Viroclinics Biosciences B.V. ("Viroclinics") today announced the appointment of life sciences industry veteran Davide Molho, DVM as the company's new Chief Executive Officer. Dr. Molho succeeds Bob van Gemen, PhD who has served as the company's CEO since 2011. This transition is part of a planned succession strategy. Dr. ...

more
26.06.2020 – 13:04

Zhejiang Hisun Pharmaceutical Co. Ltd.
Free of COVID-19, Governments Suggest Favipiravir

more
22.06.2020 – 12:49

Zhejiang Hisun Pharmaceutical Co. Ltd.
Hisun Pharmaceutical: Free of COVID-19, Governments Suggest Favipiravir

more
26.03.2020 – 14:34

Bosch Healthcare Solutions GmbH

2
Bosch developing COVID-19-(SARS-CoV-2) rapid testing kit for the Vivalytic platform / Test delivers reliable results at the point of care in less than 2.5 hours

more
16.12.2019 – 13:17

Cilian AG

New in-vivo study confirms that ciliate vaccine protects against flu

more

1